We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

21 hedge funds and large institutions have $15.6M invested in Yield10 Bioscience, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

912% more capital invested

Capital invested by funds: $1.54M → $15.6M (+$14.1M)

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

163% more funds holding

Funds holding: 8 → 21 (+13)

Holders
21
Holders Change
+13
Holders Change %
+162.5%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
3
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$5.36M
2
Morgan Stanley
Morgan Stanley
New York
+$2.85M
3
WVP
Worth Venture Partners
New Jersey
+$1.26M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.09M
5
Millennium Management
Millennium Management
New York
+$965K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$81.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$4.76M +$5.36M +15,833 New
Morgan Stanley
2
Morgan Stanley
New York
$2.53M +$2.85M +8,420 New
CC
3
Cannell & Co
New York
$2M +$209K +618 +10%
WVP
4
Worth Venture Partners
New Jersey
$1.12M +$1.26M +3,721 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$972K +$1.09M +3,232 New
Millennium Management
6
Millennium Management
New York
$859K +$965K +2,853 New
Marshall Wace
7
Marshall Wace
United Kingdom
$474K +$532K +1,574 New
BlackRock
8
BlackRock
New York
$473K – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$459K -$81.9K -242 -14%
MWNA
10
Marshall Wace North America
New York
$396K +$444K +1,312 New
Two Sigma Investments
11
Two Sigma Investments
New York
$394K +$136K +401 +44%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$384K +$432K +1,278 New
FC
13
Fairpointe Capital
Illinois
$251K +$282K +833 New
BC
14
Birchview Capital
Vermont
$238K – – –
Two Sigma Advisers
15
Two Sigma Advisers
New York
$219K +$247K +729 New
TRCT
16
Tower Research Capital (TRC)
New York
$53K +$44K +130 +277%
UBS Group
17
UBS Group
Switzerland
$10K +$11.8K +35 New
Rockefeller Capital Management
18
Rockefeller Capital Management
New York
$7K +$7.78K +23 New
HDIM
19
Hanson & Doremus Investment Management
Vermont
$3K – – –
RMC
20
Resources Management Corp
Connecticut
$3K +$3.38K +10 New

YTEN Hedge Fund Activity: Q1 2021 in Review

21 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2021, worth a combined $15.6M — up 912% from $1.54M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new YTEN positions and 0 closed out — a net gain of 13 holders — while 3 added to existing stakes and 1 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $5.36M. The largest seller was Renaissance Technologies, cutting an estimated $81.9K.

  • 21 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2021, up from 8 in Q4 2020.
  • Funds reported $15.6M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2021, up 912% quarter-over-quarter.
  • 13 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +13 holders.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2021 was AIGH Capital Management, an estimated $5.36M added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2021 was Renaissance Technologies, an estimated $81.9K sold.

Based on aggregated 13F filings for Q1 2021.